ANV419
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for ANV419, covering 2024-11-08 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: ACT-TIL and ANV419 for Advanced Melanoma. [Phase 1]